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The	 photochemical	 thiol-ene	 reaction	 as	 a	 versatile	method	 for	
the	synthesis	of	glutathione	S-conjugates	 targeting	 the	bacterial	
potassium	efflux	system	Kef 
Jess	Healy,a,b,*	Tim	Rasmussen,c	Samantha	Miller,c	Ian	R.	Booth,c	Stuart	J.	Conwaya,*	
Abstract	The	 thiol-ene	 coupling	 reaction	 is	 emerging	 as	 an	 important	 conjugation	 reaction	 that	 it	 suitable	 for	 use	 in	 a	
biological	 setting.	 	 Here,	we	 explore	 the	 utility	 of	 this	 reaction	 for	 the	 synthesis	 of	 glutathione-S-conjugates	 (GSX)	 and	
present	a	general,	operationally	simple,	protocol	with	a	wide	substrate	scope.	The	GSX	afforded	are	an	important	class	of	
compounds	 and	 provide	 invaluable	 molecular	 tools	 to	 study	 glutathione-binding	 proteins.	 In	 this	 study	 we	 apply	 the	
diverse	 library	 of	 GSX	 synthesised	 to	 further	 our	 understanding	 of	 the	 structural	 requirements	 for	 binding	 to	 the	
glutathione-binding	protein,	Kef,	a	bacterial	K+	efflux	system,	found	in	many	bacterial	pathogens.	This	system	is	vital	to	the	
survival	of	bacteria	upon	exposure	to	electrophiles,	and	plays	an	essential	role	in	the	maintenance	of	intracellular	pH	and	
K+	homeostasis.	Consequently,	Kef	is	an	appealing	target	for	the	development	of	novel	antibacterial	drugs.	
Introduction		
The	 rapid	 and	 continual	 rise	 of	 bacterial	 resistance	 to	 many	
frontline	 antibiotic	 treatments	 necessitates	 the	 urgent	
identification	 of	 novel	 antibiotic	 targets.1	 Consequently,	 the	
development	 of	 small	 molecule	 ligands	 that	 modulate	 the	
activity	 of	 such	 targets	 will	 be	 essential	 in	 the	 validation	 of	
their	therapeutic	potential.	The	bacterial	potassium	(K+)	efflux	
system,	 Kef,	 is	 a	 K+	 /	 H+	 antiporter	 that	 plays	 a	 vital	 role	 in	
promoting	 cell	 survival	 by	 modulating	 cytoplasmic	 pH	 during	
electrophilic	 insult.	 Kef-like	 systems	 are	 found	 across	 the	
spectrum	 of	 bacteria,	 including	 in	 the	 ESKAPE	 pathogens,	
which	 are	 responsible	 for	 the	 majority	 of	 hospital	 acquired	
infections.2		
	
The	 Kef	 system	 integrates	 detoxification	 of	 electrophiles	 via	 GSH	
metabolites	 with	 activation	 of	 K+	 efflux.	 Kef’s	 protective	 effect	
stems	from	the	associated	drop	in	the	cytoplasmic	pH	on	activation	
of	 K+	 efflux,	 which	 is	 thought	 to	 result	 in	 protonation	 of	 the	
nucleophilic	 groups	 on	 DNA	 and	 proteins	 –	 preventing	 damage	
caused	by	exposure	to	electrophiles.3	Previous	work	has	shown	the	
magnitude	and	rate	of	activation	of	Kef	to	be	a	vital	determinant	in	
cell	survival	on	exposure	to	toxic	electrophiles.	Kef	thus	presents	an	
appealing	target	for	antibiotic	drug	development.4,5	The	archetypal	
E.	 coli	 Kef	 system	 is	 a	 complex	 multi-domain	 membrane	 protein,	
which	contains	a	cytosolic	ligand-binding	KTN	domain.	It	 is	 inactive	
in	 the	 presence	 of	 GSH,	 and	 activated	 by	 GSH	 conjugates	 (GSX)	
formed	on	exposure	of	the	cell	to	electrophiles.	Evidence	garnered	
through	a	combination	of	classical	mutagenesis	and	crystallographic	
studies	led	to	the	proposal	of	a	model	for	regulation	of	K+	efflux	by	
the	negative	and	positive	effectors,	GSH	and	GSX,	respectively.3	The	
peptide	 core	 is	 tethered	 at	 either	 end	 by	 a	 number	 of	 key	 basic	
residues,	 R416,	 R516	 and	 N551.	 Mutagenesis	 had	 previously	
identified	 these	 residues	 as	 vital	 for	 GSH/GSX	 recognition,6	 and	
crystallography	confirmed	their	 importance	as	key	contacts	for	the	
peptide	 backbone	 (Figure	 1).	 Crystallography	 also	 suggested	 a	
conformational	 change	 on	 binding	 of	 GSX,	 particularly	 around	
residue	F441	that	caps	the	thiol-binding	site	in	what	is	proposed	to	
be	 a	 ‘closed’	 conformation.	 This	 hypothesis	 was	 tested	 by	 site	
directed	 mutagenesis,	 where	 conservative	 changes	 (e.g.	 F441W)	
had	 little	effect	on	gating	but	more	disruptive	changes	 (e.g.	F441L	
or	F441D)	resulted	 in	significantly	 impaired	activation	of	K+	efflux.3	
Thus	 F441	was	 proposed	 to	 be	 involved	 in	 activation	 of	 K+	 efflux.	
‘Chemical	 mutagenesis’,	 i.e.	 investigation	 of	 the	 effect	 of	 varying	
the	nature	of	the	thiol	substituent	on	both	binding	and	gating,	was	
consistent	with	the	proposed	model	for	channel	activation.7	 In	our	
previous	study,	a	number	of	ESG	(S-N-ethylsuccinimidyl	glutathione)	
analogues	were	examined	and	it	was	found	that	larger	substituents	
Page 1 of 8 Org nic Chemistry Frontiers
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
O
rg
an
ic
C
he
m
is
tr
y
Fr
on
tie
rs
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
15
 F
eb
ru
ar
y 
20
16
. D
ow
nl
oa
de
d 
on
 1
5/
02
/2
01
6 
10
:3
0:
11
. 
View Article Online
DOI: 10.1039/C5QO00436E
ARTICLE	 Organic	Chemistry	Frontiers	
2 	|	Org.	Chem.	Front.	.,	2012,	00,	1-3	 This	journal	is	©	The	Royal	Society	of	Chemistry	20xx	
Please	do	not	adjust	margins	
Please	do	not	adjust	margins	
on	 the	 nitrogen	 atom	 of	 the	 succinimidyl	 ring	 including	 tBu	 (KD	 =	
400	nM),	 Bn	 and	 Cy	 had	 a	 higher	 affinity	 for	 Kef	 than	 the	 parent	
compound.	Additionally,	open	chain	analogues	containing	5,	6	or	8	
(KD	=	4.4	µM)	carbons	bound	with	similar	affinity	to	ESG,	indicating	
that	 an	 increase	 in	 hydrophobicity	 and	 size	 corresponded	 to	 an	
increase	 in	 affinity	 for	 the	 target.	 However,	 examination	 of	 the	
effect	 of	 these	 GSX	 on	 the	 rate	 of	 K+	 efflux,	 revealed	 a	
differentiation	 between	 affinity	 and	 gating.	 The	 structurally	 rigid	
succinimidyl	analogues	were	efficient	activators,	whereas	the	more	
flexible	 analogues	 resulted	 in	 a	 lower	 rate	 of	 K+	 efflux,	 despite	
similar	 affinities.	 These	 data	 suggest	 that	 a	 degree	 of	 structural	
rigidity	in	the	S-substituent	is	required	for	efficient	gating	of	Kef.	
	
Figure	 1.	 The	 GSH	 (carbon	 =	 yellow)	 binding	 site	 of	 E.	 coli	 KefC,	 highlighting	 key	
residues.	 This	 figure	 was	 generated	 with	 PyMOL	 using	 the	 GSH	 bound	 E.	 coli	 KefC	
structure	(PDB:	3L9W).	
The	ligands	employed	in	this	work	were	exclusively	formed	by	
conjugate	 addition	 of	 GSH	 to	 a	 range	 of	 enones.7	While	 this	
approach	 was	 informative	 in	 revealing	 that	 both	 steric	 bulk	
and	structural	rigidity	are	required	for	Kef	activation,	the	range	
of	 sulfur	 substituents	 that	we	 could	 employ	were	 necessarily	
limited	 by	 the	 requirement	 for	 electrophilic	 reactivity.	
Therefore,	 we	 sought	 to	 employ	 alternative	 chemistry	 to	
conjugate	 the	 thiol	 group	 of	 GSH	 to	 a	 range	 of	 structurally	
diverse	moieties.	Recent	advances	in	the	photochemical	thiol-
ene	coupling	(TEC)	reaction	led	us	to	investigate	the	use	of	this	
chemistry	to	produce	derivatives	of	GSH.	
	
The	 TEC	 reaction8-10	 is	 emerging	 as	 a	 useful	 tool	 in	 biologically-
important	 conjugation	 reactions.11	 This	 transformation,	 which	
occurs	between	thiols	and	alkenes,	has	many	attractive	features	as	
it	often	fulfils	the	‘click’	criteria	as	defined	by	Sharpless	et	al.12	The	
biocompatibility	 of	 the	 reaction	 conditions	 also	 provides	 a	 viable	
alternative	 to	 the	 Cu-catalysed	 Huisgen	 cycloaddition	 for	 the	
ligation	 of	 peptides	 and	 proteins.12-14	 Alternatives	 to	 the	 Cu-
catalysed	 Huisgen	 cycloaddition	 are	 important	 as	 the	 use	 of	 this	
reaction	 can	 be	 complicated	 by	 the	 presence	 of	 the	 Cu	
catalyst.15,16Until	 recently,	 the	 TEC	 had	 been	 predominantly	
employed	in	polymer	and	materials	chemistry,	but	recent	work	has	
firmly	established	this	reaction	in	the	field	of	bioconjugation,	where	
it	 has	 found	 applications	 in	 glycobiology,	 the	 synthesis	 of	
thioglycosides,17-21	the	detection	of	thio-phosphorylated	proteins,22	
protein	 spin	 labelling,23	 tandem	 application	 with	 native	 chemical	
ligation	 for	 the	 synthesis	 of	 S-modified	 peptides,24	 lipidated	
peptides,25	 the	 development	 of	 lipophilic	 amino	 sugar	 libraries,26	
and	 the	 synthesis	 of	 stapled	 peptides.27	 Waldmann	 et	 al.	 have	
utilised	 this	 methodology	 in	 the	 synthesis	 of	 S-lipidated	 cysteine	
derivatives,	and	more	recently	to	the	 immobilisation	of	proteins	 in	
microarrays.28-31	 The	 TEC	 has	 also	 found	 wide	 application	 in	
polymer	chemistry,32	and	biopolymer	applications,	for	example	the	
synthesis	 of	 glycol-microspheres.33	 Despite	 these	 successes,	
Dondoni11	 noted	 that	 TEC	 conditions	 are	 not	 always	 general	 and	
that	 significant	 optimisation	 can	 be	 required	 for	 each	 individual	
system.	 Additionally,	 considering	 the	 importance	 of	 glutathione	
(GSH,	4)	 in	biological	processes,	 there	have	been	 limited	examples	
of	 the	application	TEC	 to	 this	ubiquitous	peptide	and	 in	each	case	
GSH	modification	was	 not	 the	main	 focus	 of	 these	 studies.	 17-19,34	
Here,	 we	 explore	 the	 utility	 of	 the	 TEC	 reaction	 to	 generate	 a	
diverse	 library	 of	 GSX.	 This	 library	was	 subsequently	 employed	 to	
investigate	 the	requirements	 for	high	affinity	 to	 the	 ligand-binding	
domain	 of	 the	 Kef	 system	 from	 a	 model	 organism,	 Shewanella	
denitrificans	(SdKefQCTD).7	
Results	and	discussion	
Optimisation	of	thiol-ene	coupling	conditions	Our	interest	in	the	
TEC	reaction	was	motivated	by	our	desire	to	synthesise	a	stable	S-
dansyl-labelled	 GSH	 derivative	 (3,	 Scheme	 1).	 This	 molecule	 was	
required	 as	 a	 fluorescent	 probe	 to	 detect	 binding	 of	 small	
molecules	 to	Kef.7	Direct	 reaction	of	dansyl	chloride	with	 the	 thiol	
of	 GSH	 results	 in	 the	 formation	 of	 a	 scissile	 S-S	 bond,	 which	
rearranges	 to	 the	 more	 stable	 N-acyl	 compound.	 Based	 on	 our	
structure-activty	relationship	(SAR)	studies,	we	wished	to	produce	a	
GSX	 derivative	 with	 the	 fluorophore	 attached	 to	 the	 thiol.	
Therefore,	 we	 adopted	 a	 strategy	 reported	 by	Waldmann	 et	 al.31	
and	synthesised	N-allyl-5-(dimethylamino)naphthalene	sulfonamide	
(2)	from	dansyl	chloride	(1).	Installation	of	an	allyl	group	provided	a	
synthetic	handle	for	linkage	of	the	fluorophore	to	GSH	via	the	TEC,	
forming	a	 stable	 thioether	bond.	Using	 conditions	 similar	 to	 those	
reported	 by	 Fiore	 et	 al.35	 and	 Staderini	 et	 al.,36	 a	 household	 UV	
lamp	 (4	 ×	 15	 W,	 365	 nm)	 was	 used	 as	 the	 light	 source	 and	 2,2-
dimethoxyphenyl	acetophenone	(DPAP)	as	the	initiator.	Due	to	the	
disparate	 solubilites	 of	 the	 reagents,	 a	mixture	 of	 THF	 and	 water	
(1:2)	were	used	as	solvents,	allowing	for	partial	solubilisation	of	the	
alkene	substrate.	Initial	attempts	provided	the	desired	compound	in	
yields	 of	 8-14%	 (Table	 1,	 entries	 1-3).	 The	 primary	 product,	
however,	 was	 the	 disulfide	 (GSSG).	 Addition	 of	 a	 reducing	 agent	
tris(2-carboxyethyl)phosphine	 (TCEP·HCl)	 resulted	 in	 a	 significant	
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improvement	in	yield	to	40%	(Table	1,	entry	4).	Thorough	degassing	
of	 solvents	 was	 found	 to	 have	 no	 effect	 on	 the	 observed	 yield	
(Table	1,	entry	5-6).	
	
Scheme	 1.	 Synthesis	 of	 S-dansylglutathione	 (DNGSH)	 3.	 Reagents	 and	
conditions:	a.	allylamine,	 	DIPEA,	CH2Cl2,	100%	b.	GSH,	DPAP,	TCEP·HCl,	hν,	
THF/H2O,	40%.7	
	
	
Table	1.	Optimisation	of	reaction	conditions	for	the	synthesis	of	3a.	
a0.5	eq	DPAP	used	in	all	cases.	Entry	5:degassed	THF/H2O,	Entry	6:	degassed	DMF/H2O.	
bYields	 quoted	 are	 isolated	 yields	 following	 purification	 by	 RP	 C-18	 silica	 gel	 column	
chromatography.	cDenotes	addition	of	TCEP·HCl.	
	
Compound	2	is	a	challenging	substrate	for	the	TEC.	The	thiyl	radical		
reacts	more	 readily	with	electron-rich	enes	due	 to	 its	electrophilic	
nature,	 thus	 the	 initial	 rate	 of	 addition	 is	 expected	 to	 be	 slow	 for	
this	 compound.14,32,37	 Additionally,	 compound	 2	 contains	 a	
heteroatom	in	the	allylic	position	making	it	sensitive	to	elimination	
to	the	allyl	sulfide	after	the	addition	step	(Figure	2).	37,38	Given	our	
encouraging	 results	 with	 this	 challenging	 ene	 we	 were	 keen	 to	
further	 investigate	the	scope	of	 this	 reaction	for	 the	generation	of	
structurally	distinct	GSX	as	probe	compounds	for	Kef.	
	
Figure	2.	The	thiol-ene	coupling	reaction.	
	
We	 optimised	 the	 reaction	 conditions	 using	 the	 simple	 terminal	
alkene,	 decene,	 as	 a	 model	 system	 (Scheme	 2,	 5c).	 Using	 the	
conditions	 that	we	 had	 previously	 developed	 a	moderate	 yield	 of	
45%	was	obtained	(Table	2,	entry	1).	To	simplify	the	purification	of	
the	 product	 we	 excluded	 the	 reducing	 agent,	 which	 had	 no	
significant	 effect	 on	 the	 yield	 of	 S-labeled	 peptide	 obtained	 with	
this	simple	substrate.	This	result	indicates	that	the	GSSG	during	the	
formation	 of	3	 resulted	 from	 the	 slower	 reaction	 rate	 of	2	 in	 the	
TEC.	 Shortening	 the	 irradiation	 time	 was	 found	 to	 decrease	 the	
yield	 (Table	 2,	 entry	 2,	 15%),	 while	 an	 increase	 in	 the	 irradiation	
time	gave	no	improvement	(Table	2,	entry	6).	We	found,	however,	
that	the	amount	of	 initiator	could	be	reduced	to	20	mol%	without	
any	 impact	 on	 the	 isolated	 yield	 (Table	 2,	 entry	 5),	 when	 using	
decene.	 With	 standard	 conditions	 established	 using	 a	 simple	
substrate,	a	 series	of	alkenes	were	selected	 to	probe	 the	scope	of	
the	reaction,	and	which	would	provide	a	diverse	SAR	profile	for	Kef.	
	
With	 simple,	 terminal	 and	 unfunctionalised	 alkenes	 the	 yields	
ranged	from	45%	to	97%	(Scheme	2,	5a,	c,	d,	e,	g).	 Isolation	in	all	
cases	 was	 by	 filtration	 followed	 by	 crystallisation	 from	 boiling	
ethanol	and	water.	With	hexene	as	the	ene	substrate	the	resulting	
labeled	 peptide	 was	 obtained	 in	 very	 high	 yields	 (97%,	 5a).	 By	
comparison,	 reaction	 with	 cyclohexene	 resulted	 in	 a	 significantly	
lower	yield	(59%,	5b),	as	expected	due	to	increased	reversibility	of	
the	initial	thiyl	radical	addition	to	the	internal	alkene	(Figure	2).	37	
	
Table	2.	Reaction	optimisation	for	simple	alkene	system	(5c)	
entry	 DPAP		 t	(h)	 Yield	(%)b	
1	 0.5	 5	 45	
2	 0.5	 1	 15	
3	 0.2	 2	 5	
4	 0.2	 3	 18	
5	 0.2	 5	 45	
6	 0.2	 8	 31	
aRatio	 of	 GSH:decene	 (4:1),	 and	 solvent	 system	 THF/H2O	 (1:2)	 in	 all	 cases.	 bYields	
represent	isolated	yields	following	purification	by	crystallisation	from	EtOH/H2O.	
	
(−)-β-Pinene	 (5l)	 and	 (+)-α-pinene	 (5k)	 were	 both	 very	 poor	 TEC	
substrates,	with	less	than	1%	of	the	desired	adduct	isolated	in	both	
cases.	 These	 low	 yields	 could	 result	 from	 a	 number	 of	 factors:	 1)	
slow	 rate	 of	 hydrogen	 radical	 abstraction	 by	 the	 stable	 carbon	
radical,	 formed	 by	 both	 5k	 and	 5l	 could	 mask	 the	 expected	
differences	 in	 the	 rate	 of	 reaction	 with	 the	 internal	 vs	 external	
alkene;	 or	 2)	 rearrangement	 or	 fragmentation	 of	 the	 radical	
intermediate	 might	 result	 in	 unwanted	 products.	 Reaction	 with	
heteroatom-containing	allylic	substrates	(5f,	h,	i)	proceeded	well	in	
all	cases.	However,	due	to	the	 increased	solubility	of	the	hydroxyl-	
and	 amino-containing	 adducts	 (5h	 and	5i),	 purification	 by	 reverse	
phase	C-18	 silica	 gel	 column	chromatography	was	 required.	 These	
compounds	 are	 interesting,	 however,	 as	 they	 provide	 handles	 for	
further	 synthetic	 elaboration.	 The	 heterocyclic	 pyrrolidinone	 (5j)	
was	also	well	tolerated.		
A	 series	 of	 aryl-substituted,	 vinyl	 and	 allyl	 alkenes	 were	 next	
investigated	 (Scheme	 3).	 Styrene	 (Scheme	 3,	 6f)	 is	 a	 poor	 TEC	
substrate,14	 and	 in	 our	 hands	 yielded	 the	 desired	 adduct	 in	
moderate	yield	(53%).	Considering	the	reaction	mechanism	(Figure	
2),	 modification	 of	 the	 electronic	 properties	 of	 the	 aryl	 ring	 by	
substitution	was	predicted	 to	affect	 the	overall	 reaction	yield,	and	
S
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this	 was	 indeed	 found	 to	 be	 the	 case.	 Addition	 of	 electron-
withdrawing	groups	in	the	para-	(6a	and	6c)	or	ortho-	(6b)	positions	
of	the	ring	resulted	in	a	decreased	yield	of	the	adduct.	The	electron	
poor	 vinyl	 sulfone	 (6e)	 also	 resulted	 in	 a	 low	 yield	 of	 the	 labelled	
peptide.	 The	 reduced	 yields	 in	 these	 cases	 can	 be	 rationalised	 by	
either	the	low	reactivity	of	the	electrophilic	thiyl	radical	with	these	
electron-poor	 alkenes,	 or	 a	 slower	 hydrogen	 radical	 abstraction	
step.	 For	 the	 para-nitro	 analogue,	 competing	 reduction	 to	 the	
aniline	was	 also	 observed,	 and	 consequently	 the	 purity	 of	6a	was	
lower	that	of	the	other	GSX	in	this	series.	Addition	of	a	methylene	
unit	to	the	4-fluoro	derivative	improved	the	observed	yield	(6d,	90%	
cf.	 6c,	 39%),	 due	 to	 the	 loss	 of	 conjugation	 with	 the	 aromatic	
system.	 Conversely,	 addition	 of	 a	 para-methoxy	 substituent	
resulted	in	an	increase	in	yield	of	the	desired	adduct	(6g,	84%),	due	
to	the	increased	electron	density	of	the	alkene	in	this	case.	It	can	be	
seen	 from	 the	 data	 presented	 here	 that	 electron-rich	 alkenes	 are	
better	substrates	for	this	reaction	due	to	greater	reactivity	with	the	
electrophilic	 thiyl	 radical.	 This	 observation	 is	 consistent	 with	 the	
reactivities	trends	observed	in	polymer	chemistry.	14	
	
Scheme	 2.	 Scope	 of	 thiol-ene	 coupling	 to	 alkyl	 and	 heteroalkyl	 substrates.	Reagents	
and	 conditions:	 a.	 Alkene	 (1	 eq),	 DPAP,	 THF/H2O,	 hν.	 %	 yields	 quoted	 are	 isolated	
yields.	
	
	
Scheme	3.	Scope	of	 thiol-ene	coupling	 to	aryl	 substrates.	Reagents	and	conditions:	a.	
Alkene	 (1	eq),	DPAP,	THF/H2O,	 	hν.	%	yields	quoted	are	 isolated	yields.	*denotes	 the	
use	of	TCEP·HCl 
 
Electron-poor	alkenes	provide	 lower	yields	 in	 this	 reaction	as	 they	
react	less	readily	with	the	electrophilic	thiyl	radical.	Additionally,	we	
found	 that	 for	particularly	 challenging	substrates	 the	yield	may	be	
increased	by	modification	of	the	electronic	properties	of	the	ene	via	
appropriate	 substitution,	 or	 by	 the	 addition	 of	 TCEP·HCl	 as	 a	
reducing	 agent	 (Table	 1,	 entry	 4	 and	 Scheme	 3,	 6c).	 This	 second	
observation	 is	 contrary	 to	 a	 report	 by	 Scanlan	 et	 al.,	 in	 which	 an	
increase	 in	 competing	 radical	 desulfurisation	was	 observed	 in	 the	
presence	of	 tBu3P	as	 reducing	agent,	 this	was	not	observed	 in	our	
hands	with	TCEP	as	the	phosphine	reducing	agent.24	
Investigation	 of	 the	 effect	 of	 the	 nature	 of	 the	 S-substituent	 on	
Kef	binding	The	structurally	diverse	GSX	that	we	synthesised	were	
evaluated	for	their	ability	to	bind	Kef	from	S.	denitrificans.	A	soluble	
construct	 of	 Kef	 from	 S.	 denitrificans	 (SdKefQCTD),	 containing	 the	
ligand-binding	 KTN	domain,	 the	Q-linker	 (which	 links	 the	 cytosolic	
and	membrane	domains)	and	a	10-residue	regulatory	loop	from	the	
membrane	domain	(GHELEVDIEP),	was	employed	for	all	biophysical	
analyses	 and	 was	 purified	 as	 previously	 described.7	 Kef	 from	 S.	
denitrificans	 was	 used	 as	 a	model	 system	 as	 it	 lacks	 the	 ancillary	
cytoplasmic	 protein	 subunit	 KefF,	 which	 is	 required	 for	 full	
activation	 in	 E.	 coli,	 and	 could	 complicate	 biophysical	 analysis	 of	
ligand	binding.		
Two	 complementary	 methods	 were	 employed	 to	 examine	 ligand	
binding	to	SdKefQCTD:	differential	scanning	fluorimetry	(DSF)39	and	
a	fluorescence	competition	assay	using	DNGSH	(3).	DSF	relies	on	an	
increase	in	fluorescence	that	results	from	SYPRO	orange	binding	to	
hydrophobic	 regions	 of	 a	 soluble	 protein	 that	 are	 exposed	 by	
thermally-induced	protein	unfolding,	 giving	a	melting	 temperature	
for	 the	 protein	 (Tm).	 Repeating	 the	 process	 in	 the	 presence	 of	 a	
ligand	(that	binds	to	a	folded	state	of	the	protein)	usually	results	in	
an	 increase	 in	 Tm.	 The	 change	 in	 Tm	between	 the	 free	 and	 ligand-
bound	protein	(ΔTm)	correlates	with	ligand’s	affinity	for	the	protein.	
40-42	
	
Figure	3.	Fluorescence	competition	(A	and	C)	and	DSF	(B	and	D)	data	for	GSX.	Error	bars	
represent	the	standard	deviation	(n	=	3).	Significance	of	changes	evaluated	by	Student’s	
t-test	relative	to	GSH	(where	****	p	≤	0.0001,	***	p	≤	0.001,	**	p	≤	0.01.	*	p	≤	0.05).	
FB/FL	=	FI(Kef	+	3)/FI(Kef	+	3	+	GS-X)	and	ΔTM	is	the	difference	in	TM	in	the	presence	of	
ligand	relative	to	that	of	the	protein	alone.		
	In	depth	biophysical	evaluation	of	compound	3,	which	is	employed	
in	 the	 fluorescence	 competition	 assay,	 has	 been	 described	
previously.7	 Briefly,	 the	 dansyl	 chromophore	 is	 a	 solvatochromic	
probe,	 which	 is	 sensitive	 to	 the	 nature	 of	 its	 environment.	 On	
binding	 to	 SdKefQCTD,	 i.e.	 a	 transition	 from	 a	 hydrophilic	 to	 a	
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hydrophobic	environment,	both	an	increase	in	the	quantum	yield	of	
fluorescence	of	3	and	a	hypsochromic	shift	 in	 the	λmax	of	emission	
are	 observed.	 Displacement	 of	 the	 probe	 by	 a	 competing	 ligand	
results	 in	 a	 drop	 in	 fluorescence	 intensity	 that	 can	 be	 used	 to	
identify	 new	 ligands	 for	 SdKefQCTD.	 Quantitative	 data	 can	 be	
obtained	 by	 titration	 of	 SdKefQCTD	 and	 3	 with	 increasing	
concentrations	of	the	competing	ligand,	and	fitting	of	the	resulting	
binding	isotherm.	Good	correlation	of	the	data	obtained	using	both	
methods	 was	 observed,	 as	 previously	 reported.	 Additionally	 FB/FL	
values	 (where	 FB	 =	 fluorescence	 intensity	3	 +	SdKefQCTD	and	 FL	 =	
fluorescence	 intensity	 3	 +	 SdKefQCTD	 +	 GSX	 and	 an	 FB/FL	 >	 1	
indicates	binding),	have	shown	good	correlation	with	 the	affinities	
obtained	using	quantitative	methods.7		
Evaluation	of	the	aliphatic	and	heteroatom	containing	GSX	(Scheme	
2,	 5a-5j)	 demonstrated	 that	 compounds	 with	 simple	 aliphatic	
substituents	 bound	with	 a	 similar	 affinity	 to	 the	 known	 ESG	 (KD	 =	
12	µM)	 (Figure	3A	and	B).7	 The	 smaller,	more	polar,	 analogues	5h	
and	 5i	 were	 found	 to	 bind	 to	 SdKefQCTD	 with	 a	 lower	 affinity,	
similar	 to	 that	 observed	 for	 the	 native	 ligand	 GSH	 (KD	 =	 900	µM)	
(Figure	 3,	 A	&	 B),	 and	 a	 known	weak	 activator	 of	E.	 coli	 Kef	 C,	 S-
lactoyl	glutathione	(SLG,	KD	=	900	µM).	A	small	recovery	in	binding	
efficiency	was	observed	for	the	larger	pyrrolidinone	analogue	5j.		
For	 the	aromatic	analogues	 (Scheme	3,	6a-6g),	SdKefQCTD	binding	
of	a	similar	magnitude	to	the	positive	control	ESG	was	observed	in	
all	 cases	 (Figure	3,	C	&	D).	The	analogue	containing	 the	para-nitro	
(6a)	 substituent	and	the	unsubstituted	derivative	6f	were	 the	only	
cases	for	which	a	statistically	significant	 increase	in	binding	affinity	
relative	to	ESG	was	observed	in	the	fluorescence	assay	(p	≤	0.05	in	
both	cases).	Also	of	note,	 is	a	 reduction	 in	SdKefQCTD	affinity	was	
observed	 for	 the	 4-F	 derivative	 (6c),	 which	 could	 be	 recovered	
through	the	 introduction	of	an	additional	methylene	unit	between	
the	sulfur	atom	and	the	aromatic	ring	(6d).	
Conclusions	
In	conclusion,	we	have	shown	that	the	TEC	is	a	simple,	versatile	and	
reliable	 method	 for	 the	 synthesis	 of	 novel	 GSH	 derivatives.	 The	
conditions	 that	 we	 have	 developed	 are	 operationally	 simple	 and	
high	yielding.	It	is	noteworthy	that	in	all	cases,	no	effort	was	made	
to	 exclude	 oxygen.	 For	 most	 substrates	 the	 product	 could	 be	
isolated	 by	 simple	 filtration	 and	 purified	 by	 crystallisation	 from	
ethanol	 and	 water.	 Most	 significantly,	 for	 more	 challenging	
substrates	 the	 yield	 can	 be	 improved	 through	 the	 addition	 of	 a	
reducing	agent	(TCEP·HCl).		
The	 diverse	 library	 of	 GSX	 synthesised	 using	 this	 methodology	
contained	 analogues	 with	 simple	 aliphatic	 (cyclic	 and	 acyclic)	
substituents,	 small	 polar	 heteroatom	 containing	 functional	 groups	
and	a	 series	of	 substituted	styrenes.	This	 set	of	probe	compounds	
was	tested	for	their	ability	to	bind	to	SdKefQCTD,	and	it	was	found	
that	 those	 ligands	 containing	 bulky,	 hydrophobic	 substituents	
bound	 with	 greater	 affinity	 than	 those	 with	 small	 polar	 groups.	
These	data	enhance	our	understanding	of	Kef	SAR,	and	is	invaluable	
for	our	continued	understanding	of	the	Kef	system	and	attempts	to	
determine	whether	this	protein	is	a	therapeutically	useful	target	for	
antibacterial	drugs.	The	compounds	will	also	potentially	find	use	in	
the	investigation	of	other	GSH-binding	proteins.	
Experimental	section	
Strains	 and	 plasmids	 The	 strains	 and	 plasmids	 used	 in	 this	 study	
were	 described	 previously.7	 Briefly,	 the	 strain	 used	 for	 protein	
expression	 and	 purification	 was	 MJF373	 (derived	 from	 MJF276	
ΔkefFC∷kan,	 Δcrp	 kefB∷Tn10).	 A	 soluble	 construct,	
pTrcSdKefQCTD,	 of	 Kef	 from	 S.	 denitrificans	 was	 used	 for	 protein	
expression.	The	construct	was	derived	from	pTrcSdKefH6	of	the	Kef	
gene	 from	 S.	 denitrificans	 OS217	 (accession	 number	 NC007954.1)	
starting	 at	 K391	 with	 a	 further	 10	 amino	 acid	 sequence	
(GHELEVDIEP)	 fused	 at	 the	 5’	 end	 (corresponds	 to	 a	 suspected	
regulatory	loop).	
Protein	 expression	 and	 purification	 pTrcSdKefQCTD	 was	
transformed	 into	 the	E.	 coli	 strain	MJF373	 for	expression.	The	 cell	
culture	was	grown	in	LB	media	(0.5	L,	containing	0.1%	glucose)	at	37	
°C	until	an	OD650	of	0.8	was	reached.	After	this	time	the	culture	was	
cooled	to	30	°C,	followed	by	induction	with	IPTG	(0.8	mM).	The	cells	
were	incubated	at	this	temperature	for	a	further	3	h,	harvested	and	
stored	 at	 −80	 °C	 until	 required.	 Cell	 lysis	 was	 achieved	 using	 a	
French	Press	(SLM	Aminco)	at	a	pressure	of	18k	psi.		The	lysate	was	
centrifuged	(4700	rpm,	30	min,	4	°C)	and	the	supernatant	collected	
and	filtered	(Sartorius	Minisart	single	use	filter,	0.45	µm	pore	size).	
The	 lysate	 was	 loaded	 into	 a	 glass	 column	 containing	 His-Select	
Nickel	affinity	gel	(under	gravity	at	4	°C),	washed	with	wash	buffer	
(40	 mL	 containing:	 50	 mM	 Na-phosphate	 buffer	 pH	 7.5,	 150	mM	
NaCl,	 10%	 glycerol,	 20	 mM	 imidazole).	 Bound	 protein	 was	
subsequently	eluted	(50	mM	Na-phosphate	buffer	pH	7.5,	150	mM	
NaCl,	 10%	 glycerol,	 300	 mM	 imidazole).	 Buffer	 exchange	 was	
achieved	 using	 PD-10	 columns	 (GE	 Healthcare).	 The	 purity	 of	
resulting	 protein	 was	 verified	 by	 SDS-PAGE	 gel	 electrophoresis.	
Protein	 concentration	 was	 determined	 by	 UV/VIS	
spectrophotometry	(ε	=	17420	M-1	cm-1).	
Differential	 scanning	 fluorimetry	 Assays	 were	 performed	 using	 a	
Stratagene	Mx3005P	 qPCR	 (Sybr	 filter,	 ex.	 492	 nm,	 em.	 516	 nm).	
The	initial	temperature	was	set	to	25	°C,	increasing	in	increments	of	
1	 °C.	The	TM	(melting	temperature)	was	 identified	by	 fitting	to	the	
Boltzmann	 equation	 (Prism	 5).39	 The	 change	 in	 unfolding	
temperature	(ΔTM)	was	calculated	as	the	shift	 in	TM	relative	to	the	
TM	of	the	protein	in	the	absence	of	any	ligand.	A	Student	T-test	was	
performed	to	ensure	that	the	changes	were	statistically	significant.		
Solutions	of	the	ligands	under	examination	were	prepared	in	DMSO	
or	dH2O	at	a	 final	concentration	of	100	mM.	These	stock	solutions	
were	 subsequently	 diluted	 to	 a	 concentration	 of	 10	mM	 in	 buffer	
containing	50	mM	Na-phosphate,	150	mM	NaCl,	pH	7.5.	A	protein	
master	mix	was	prepared	containing	SdKefQCTD	(40	µM)	and	Sypro	
Orange	(1:1000	dilution,	Invitrogen).	Ninety-six	well	plates	(Axygen)	
were	prepared	using	 the	protein	master	mix	 (22.5	µL,	12	µM)	and	
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the	appropriate	 ligand	(2.5	µL).	Controls	were	performed	with	dye	
alone,	ligand	and	dye,	and	the	protein	alone.		
Fluorescence	 measurements	 For	 qualitative	 competition	
fluorescence	 measurements	 a	 Perkin	 Elmer	 Luminescence	
Spectrometer	was	used.	 Samples	were	excited	at	340	nm	and	 the	
emission	spectra	measured	between	400	&	600	nm.	Samples	were	
prepared	containing	6	μM	SdKefQCTD	and	5	μM	DNGSH.	A	decrease	
in	 fluorescence	 intensity	 after	 the	 addition	 of	 the	 desired	
competing	ligand,	at	a	final	concentration	of	1	mM,	was	interpreted	
as	an	indication	of	binding.	The	data	are	reported	as	the	ratio	of	the	
fluorescence	 intensity	 before	 and	 after	 the	 addition	 of	 the	 ligand	
under	 examination	 at	 525	 nm	 (FB/FL).	 A	 Student’s	 T-test	 was	
performed	 to	 determine	 whether	 the	 changes	 were	 statistically	
significant.			
Synthetic	 chemistry	 general	 information	 All	 reagents	 were	
purchased	from	Sigma	Aldrich	or	Alfa	Aesar	and	were	used	without	
further	purification.	The	UV	 light	 source	was	provided	by	a	Philips	
HB175	Facial	Solarium	(UVA,	365	nm,	P	=	4	×	15	W).	Reverse	phase	
column	chromatography	was	carried	out	on	Fluka	Ltd	silica	gel	100	
C18-reversed	 phase,	 under	 a	 positive	 pressure	 of	 compressed	 air.	
Analytical	 TLC	 analysis	was	performed	using	Merck	60	RP-18	 F254S	
aluminium-supported	 thin	 layer	 chromatography	 sheets	 and	
visualised	using	ninhydrin.	 1H	and	 13C	NMR	spectra	were	 recorded	
on	a	Bruker	Avance	400	(400	MHz,	100	MHz,	respectively)	or	Bruker	
Avance	 III	 (500	 MHz,	 125	 MHz,	 respectively).	 1H	 and	 13C	 spectra	
were	 assigned	 using	 2D	 NMR	 experiments	 including	 COSY,	 HSQC	
and	 HMBC.	 Melting	 points	 were	 performed	 on	 a	 Kofler	 Hotstage	
microscope	 and	 are	 uncorrected;	 the	 crystallisation	 solvent	 is	
shown	 in	 parentheses.	 IR	 spectra	 were	 recorded	 using	 a	 Bruker	
Tensor	27	spectrometer.	Elemental	analyses	were	submitted	to	the	
Elemental	Analysis	Service,	London	Metropolitan	University.	Optical	
rotations	were	recorded	at	20	°C	at	the	sodium	D	line	(589	nm).	ESG	
was	 prepared	 as	 previously	 reported.3	 Selected	 examples	 of	
synthetic	 procedures	 are	 included	 below.	 Further	 details	 are	
available	in	the	Supplementary	Information.	
N-Allyl-5-(dimethylamino)naphthalene-1-sulfonamide	 (2).	 To	
allylamine	 (21	 mg,	 28	 μL,	 0.37	 mmol,	 1	 eq),	 and	
diisopropylethylamine	(239	mg,	1.85	mmol,	5	eq)	in	CH2Cl2	(5	mL)	a	
solution	 of	 dansyl	 chloride	 (100	 mg,	 0.37	 mmol,	 1	 eq)	 in	 CH2Cl2	
(3	mL)	was	added.	The	reaction	was	stirred	at	RT	overnight.	After	18	
h	 the	 reaction	 was	 adjudged	 to	 be	 complete	 by	 TLC	 analysis,	
concentrated	 in	 vacuo	 and	 purified	 by	 silica	 gel	 column	
chromatography	 eluting	 with	 ethyl	 acetate	 and	 petroleum	 ether	
(20:80),	 furnishing	 N-allyl-5-(dimethylamino)naphthalene-1-
sulfonamide	 (109	 mg,	 100%)	 as	 a	 fluorescent	 yellow	 crystalline	
solid:	Rf	0.15	(ethyl	acetate/petroleum	ether	20:80);	m.p.	62-66	°C	
(CH2Cl2);	 vmax	 (thin	 film)/cm
−1;	 1644,	 (s),	 1316	 (m);	 1H	 NMR	
(400	MHz,	CDCl3):	δ	8.56	(d,	J	=	8.6	Hz,	1H,),	8.30	(d,	J	=	8.6	Hz,	1H),	
8.26	 (d,	 J	=	8.6	Hz,	1H),	7.58	 (dd,	 J	=	7.8,	1.1	Hz,	1H),	7.53	 (dd,	 J	=	
7.8,	1.1	Hz,	1H),	7.2	(d,	J	=	7.6	Hz,	1H),	5.69-5.57	(m,	1H),	5.09	(ddt,	J	
=	17.0,	1.2	Hz,	1H),	5.01	(ddt,	J	=	10.2,	1.2	Hz,	1H),	4.75	(t,	J	=	6.2	Hz,	
1H),	3.54	(ddd,	J	=	12.2,	6.2,	1.2	Hz,	2H),	2.90	(s,	6H);	13C	NMR	(100	
MHz,	 CDCl3):	 δ	 151.9,	 134.7,	 133.0,	 130.5,	 129.8,	 129.6,	 129.6,	
128.4,	 123.2,	 118.8,	 117.5,	 115.3,	 45.8,	 45.4;	 HRMS	 m/z	 (ES+)	
[Found;	(M+Na)+	313.0891	C15H18N2NaO2S	 	requires	M
+,	313.0987];	
m/z	289.10	([M-H]−,	100%);	Anal.	Calcd.	for	C15H18N2O2S:	C,	62.0;	H,	
6.2;	N,	9.6.	Found:	C,	62.0;	H,	6.3;	N,	9.6.7		
S-((5-(Dimethylamino)naphthalen-1-yl)sulfonylaminopropyl)	
glutathione	 (3).	 N-Allyl-5-(dimethylamino)naphthalene-1-
sulfonamide	(100	mg,	0.34	mmol,	1	eq),	L-glutathione	(420	mg,	1.36	
mmol,	 4	 eq),	 TCEP·HCl	 (194	 mg,	 0.68	 mmol,	 2	 eq)	 and	 2,2-	
dimethoxyphenyl	 acetophenone	 (17	mg,	 0.07	mmol,	 0.2	 eq)	were	
stirred	 at	 RT	 in	 THF/H2O	 (1:2,	 3	 mL)	 in	 the	 presence	 of	 light	
(365	nm,	 4	 ×	 15	 W)	 for	 5	 h.	 After	 which	 time	 the	 reaction	 was	
extracted	with	CH2Cl2	(2	×	5	mL).	The	aqueous	layer	was	lyophilised	
and	 the	 crude	 material	 purified	 by	 RP	 C-18	 silica	 gel	 column	
chromatography	 (MeOH/H2O	 0:100,	 50:50),	 furnishing	 S-((5-	
(dimethylamino)naphthalen-1-yl)sulfonylaminopropyl)	glutathione	3	
(88	 mg,	 40%)	 as	 a	 hygroscopic	 yellow	 solid:	 Rf	 0.35	 (MeOH:H2O	
50:50);	 −19.2	(c	0.25,	H2O);	vmax	(PTFE	card)/cm
−1;	3057	(w),	
1719	(m),	1647	(m),	1527	(m),	1153	(m);	1H	NMR	(500	MHz,	D2O):	δ	
8.35	(d,	J	=	8.5	Hz,	1H),	8.15	(d,	J	=	8.5	Hz,	1H),	8.11	(d,	J	=	7.5	Hz,	
1H),	7.88-7.55	(m,	2H),	7.26	(d,	J	=	7.5	Hz,	1H),	4.20	(dd,	J	=	8.5,	5.1	
Hz,	1H),	3.67-3.52	(m,	3H),	2.85	(t,	J	=	6.8	Hz,	2H),	2.73	(s,	6H),	2.43	
(dd,	J	=	13.9,	5.1	Hz,	1H),	2.39-2.28	(m,	3H),	2.07	(t,	J	=	6.8	Hz,	2H),	
2.04-1.96	 (m,	 2H),	 1.34	 (qn,	 J	 =	 6.8	 Hz,	 2H);	 13C	 NMR	 (125	MHz;	
D2O):	 δ	 176.0,	 174.7,	 173.9,	 171.6,	 151.3,	 133.9,	 130.1,	 129.9,	
128.9,	 128.8,	 128.7,	 128.3,	 123.9,	 119.0,	 115.9,	 54.1,	 52.8,	 44.8,	
43.2,	40.7,	32.5,	31.4,	28.2,	27.6,	26.2;	HRMS	m/z	(ES−)	[Found;	(M-
H)−	596.1852	C25H34N5O8S2	requires	M
−,	596.1854];	m/z	 (ES−)	596.2	
([M-H]−,	 100%);	 Anal.	 Calcd	 for	 C25H35N5O8S2:	 C,	 50.2;	 H,	 5.9;	 N,	
11.7.	Found	50.1;	H,	5.7;	N,	11.7.7	
General	 procedure	 for	 the	 synthesis	 of	 GSX.	 The	 desired	 alkene	
(0.34	mmol,	1	eq),	L-glutathione	(420	mg,	1.36	mmol,	4	eq)	and	2,2-
dimethoxyphenyl	 acetophenone	 (17	mg,	 0.07	mmol,	 0.2	 eq)	were	
stirred	 at	 RT	 in	 THF/H2O	 (1:2,	 3	 mL)	 in	 the	 presence	 of	 light	
(365	nm,	4	×	15	W)	for	5	h.	After	this	time	the	reaction	mixture	was	
filtered,	 and	 the	 solid	washed	with	 ethanol	 and	water.	 The	 crude	
solid	 was	 further	 purified	 by	 crystallisation	 from	 boiling	 H2O	 and	
ethanol	 (×2)	 unless	 otherwise	 stated.	 [Note:	where	 no	 precipitate	
formed,	 the	 reaction	 was	 washed	 with	 dichloromethane	 (×2)	 and	
the	aqueous	 layer	 lyophilized.	 In	 this	 case,	 the	crude	material	was	
purified	by	RP	C-18	silica	gel	column	chromatography].	Data	shown	
for	selected	examples	see	SI	for	further	details.	
S-Propyl-3-trimethylsilylglutathione	 (5f)	 was	 isolated	 as	 a	
colourless	solid	(120	mg,	85%):	Rf	0.16	(MeOH/H2O	50:50);	 	
−29.0	 (c	0.5,	2	M	NaOH);	m.p.	228	°C	 (dec.)	 (EtOH/H2O);	vmax	 (thin	
film)/cm−1;	3372	 (m),	3345	 (m),	2954	 (m),	1672	 (s),	1645	 (s),	1513	
(s)	1432	(m);	1H	NMR	(400	MHz,	D2O/NaOD,	pH	12):	δ	4.83	(dd,	J	=	
9.2,	4.9	Hz,	1H),	3.65	 (d,	 JAB	 =	17.3	Hz,	1H),	3.58	 (d,	 JBA	 =	17.3	Hz,	
1H),	3.11	(dd,	J	=	7.2,	6.0	Hz,	1H),	2.93	(dd,	J	=	14.2,	4.9	Hz,	1H),	2.69	
(dd,	J	=	14.2,	9.2	Hz,	1H),	2.50-2.39	(m,	2H),	2.30-2.15	(m,	2H),	1.87-
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1.63	(m,	2H),	1.50-1.38	(m,	2H),	0.44	(t,	J	=	8.1	Hz,	2H),	−0.16	(s,	9H);	
13C	NMR	(125	MHz,	D2O/NaOD,	pH	12):	δ	182.8,	176.6,	176.5,	172.4,	
55.9,	53.6,	43.8,	35.7,	32.6,	31.3,	31.2,	24.2,	15.8,	−1.8;	HRMS	m/z	
(ES−)	 [Found;	 (M-H)−	 420.1638.	 C16H30N3O6SSi	 requires	 M
−,	
420.1360.];	 m/z	 (ES−)	 420.1	 ([M-H]−,	 100%);	 Anal.	 Calcd.	 for	
C16H31N3O6SSi:	C,	45.6;	H,	7.4;	N,	9.9.	Found	C,	45.6;	H,	7.4;	N,	10.1.	
2-(2-Oxopyrolid-1-yl)-S-ethyl	 glutathione	 (5j)	 was	 isolated	 as	 a	
hygroscopic	 colourless	 solid	 (118	 mg,	 83%):	 Rf	 0.6	 (H2O);	 	
−27.4	(c	0.5,	H2O);	vmax	(thin	film)/cm
−1;	3340	(w),	2360	(s),	1740	(s),	
1652	(m),	1558	(m);	1540	(m),	1291	(w);	1H	NMR	(400	MHz,	D2O):	δ	
4.44	(dd,	J	=	8.6,	5.1	Hz,	1H),	3.84	(s,	2H),	3.69	(dd,	J	=	6.4,	6.4	Hz,	
1H),	3.42-3.33	(m,	4H),	2.94	(dd,	J	=	14.2,	5.1	Hz,	1H),	2.76	(dd,	J	=	
14.2,	8.6	Hz,	1H),	2.67	(t,	J	=	6.5	Hz,	2H),	2.47-2.36	(m,	2H),	2.31	(t,	J	
=	7.5	Hz,	2H),	2.09-1.99	(m,	2H),	1.91	(qn,	J	=	7.5	Hz,	2H);	13C	NMR	
(100	 MHz,	 D2O):	 δ	 178.9,	 175.0,	 173.8,	 173.7,	 172.9,	 54.0,	 53.4,	
48.2,	41.9,	41.8,	32.9,	31.5,	31.3,	29.2,	26.3,	17.6;	HRMS	m/z	 (ES−)	
[Found;	 (M-H)−	 417.1440.	 C16H25N4O7SNa	 requires	M
−,	 417.1444.];	
m/z	 (ES−)	 417.1	 ([M-H]−,	 100%);	 Anal.	 Calcd.	 for	 C16H26N4O7S:	 C,	
45.9;	H,	6.3;	N,	13.4.	Found:	C,	45.8;	H,	6.1;	N,	13.3.		
2-(2-Trifluoromethylphenyl)-S-ethyl	 glutathione	 (6b)	 was	 isolated	
as	 a	 colourless	 solid	 (64	 mg,	 39%):	 Rf	 0.4	 (H2O/MeOH	 50:50);	
	 −16.6	 (c	 0.5,	 2	M	 NaOH);	 vmax	 (thin	 film)/cm
−1;	 3434	 (w),	
1746	 (m),	 1674	 (m),	 1645	 (m),	 1514	 (s),	 1314	 (s),	 1233	 (m),	 1114	
(m);	 1H	NMR	 (400	MHz,	D2O/NaOD,	 pH	 12):	 δ	 7.60	 (d,	 J	 =	 7.8	Hz,	
1H),	7.47	(t,	J	=	7.8	Hz,	1H),	7.37	(d,	J	=	7.8	Hz,	1H),	7.30	(t,	J	=	7.8	
Hz,	1H),	4.44	(dd,	J	=	8.9,	4.7	Hz,	1H),	3.66	(d,	JAB	=	17.2	Hz,	1H),	3.58	
(d,	 JBA	 =	 17.2	Hz,	 1H),	 3.10	 (dd,	 J	 =	 7.1,	 5.9	Hz,	 1H),	 3.06-2.94	 (m,	
3H),	 2.83-2.68	 (m,	 3H),	 2.28-2.18	 (m,	 2H),	 1.82-1.62	 (m,	 2H);	 19F	
NMR	 (125	MHz,	 D2O/NaOD,	 pH	 12);	 δ
	 −58.9;	 13C	 NMR	 (125	MHz,	
D2O/NaOD,	 pH	 12):	 δ	 182.4,	 176.3,	 176.3,	 171.9,	 138.4,	 132.2,	
131.4,	127.8	(d,	J	=	29.3	Hz),	126.8,	126.8	(q,	J	=	5.7	Hz),	124.6	(d,	J	=	
270	 Hz),	 55.5,	 52.9,	 43.3,	 32.9,	 32.4,	 32.2,	 31.9,	 30.8;	 HRMS	m/z	
(ES−)	 [Found;	 (M-H)−	 478.1273.	 C19H23F3N3O6S	 requires	 M
−,	
478.1265.];	 m/z	 (ES−)	 478.1	 ([M-H]−,	 100%);	 Anal.	 Calcd.	 for	
C19H24F3N3O6S:	C,	47.5;	H,	5.0;	N,	8.8.	Found:	C,	47.7;	H,	4.9;	N,	9.1.	
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